Please try another search
For the three months ended 31 March 2021, DynacureSA (ADR) revenues was not reported. Net loss decreased 42%to EUR4M. Lower net loss reflects Research and development- Balan decrease of 69% to EUR1.8M (expense), Foreigncurrency losses increase from EUR7K (expense) to EUR6K(income). Basic Earnings per Share excluding ExtraordinaryItems increased from -EUR0.35 to -EUR0.20.
Period Ending: | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Mar 31, 2020 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -3.93 | -5.78 | -12.7 | -6.79 |
Net Income | -3.99 | -5.83 | -12.9 | -6.86 |
Period Ending: | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Mar 31, 2020 |
---|---|---|---|---|
Total Assets | 56.11 | 60.5 | 40.11 | |
Total Liabilities | 9.58 | 10.71 | 8.25 | |
Total Equity | 46.53 | 49.8 | 31.86 |
Period Ending: | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Mar 31, 2020 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 3 Months |
Cash From Operating Activities | -3.73 | -11.51 | -6.43 | -2.09 |
Cash From Investing Activities | -0.05 | -0.2 | -0.05 | -0 |
Cash From Financing Activities | -0.15 | 58.39 | 34.24 | 0.02 |
Net Change in Cash | -3.93 | 46.67 | 27.75 | -2.07 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review